Cellular Immuno-Therapy for COVID-19 ARDS Randomized Clinical Trial

NCT04865107 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Covid19
Acute Respiratory Distress Syndrome

Interventions

BIOLOGICAL: UC-MSCs
BIOLOGICAL: Placebo

Sponsor

Ottawa Hospital Research Institute

Collaborators

[object Object]